Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AnaptysBio
AddedFeb 19, 2024
UpdatedJun 18, 2026
AnaptysBio

AnaptysBio

Public

AnaptysBio: A US-based clinical-stage biotech firm specializing in cancer immunotherapy and inflammation antibodies.

HQ
San Diego, CA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

AnaptysBio, Inc., founded in the United States, is a clinical-stage biotechnology company dedicated to developing innovative immunology therapeutics. The company's core mission is to create and market antibodies that address critical needs in cancer immunotherapy and inflammation. AnaptysBio's product pipeline includes treatments for various inflammatory disorders and cancer, with a notable focus on antibodies targeting IL-36R for conditions like generalized pustular psoriasis (GPP).

Key figures associated with AnaptysBio include prominent scientists and industry experts in biotechnology. The company has garnered significant investment from institutional investors and has achieved milestones such as positive top-line results in Phase II clinical trials for imsidolimab. AnaptysBio's impact lies in its potential to transform therapeutic approaches for severe inflammatory diseases and cancer, contributing to advancements in medical treatments and patient care.

AnaptysBio - Similar Companies

Nantkwest logo

Nantkwest

INmune Bio logo

INmune Bio

inmunebio.com

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

NantBio logo

NantBio

ImmunityBio logo

ImmunityBio

immunitybio.com

argenx logo

argenx

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

HI-Bio logo

HI-Bio

hibio.com

Agenus logo

Agenus

agenusbio.com

AltruBio logo

AltruBio

MacroGenics logo

MacroGenics

macrogenics.com

Duet BioTherapeutics logo

Duet BioTherapeutics

Rapt Therapeutics logo

Rapt Therapeutics

rapt.com

ImmuneID logo

ImmuneID

AnaptysBio - Quick Facts

Who are AnaptysBio's competitors?

Companies similar to AnaptysBio include Nantkwest, INmune Bio, Santa Ana Bio and Anthera Pharmaceuticals.

When was AnaptysBio founded?

AnaptysBio was founded in 2005.

Where is AnaptysBio's headquarters located?

AnaptysBio's headquarters is located in San Diego, CA, US.

How much has AnaptysBio raised to-date?

As of Jan 1, 2017, AnaptysBio has raised a total of $85.9M (USD).

How many employees does AnaptysBio have?

AnaptysBio has 96 employees as of Feb 6, 2024.

AnaptysBio - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Immunology Therapeutics
Tags
  • Biotech
Unique IDs
  • ein: 203828755
  • secCik: 0001370053
  • ticker: ANAB
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering